Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Thoracic 2Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 2261Lung Neoplasms 1049Small Cell Lung Carcinoma 402Adenocarcinoma of Lung 154Mesothelioma, Malignant 120Breast Neoplasms 110Neoplasms 106Brain Neoplasms 101Neoplasm Metastasis 95Melanoma 72Mesothelioma 70NSCLC 69Colorectal Neoplasms 68Adenocarcinoma, Bronchiolo-Alveolar 56Thymoma 53Pancreatic Neoplasms 52Ovarian Neoplasms 46Head and Neck Neoplasms 46Carcinoma, Renal Cell 43Carcinoma 39Stomach Neoplasms 36Sarcoma 35Prostatic Neoplasms 35Esophageal Neoplasms 35Adenocarcinoma 34Uterine Cervical Neoplasms 33Squamous Cell Carcinoma of Head and Neck 33Pleural Effusion, Malignant 33Recurrence 27Urinary Bladder Neoplasms 26

Interventions

Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Ascites × Thoracic × Clear all
NCT01854866 2013-10-01

Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion

Huazhong University of Science and Technology

Phase 2 Unknown
30 enrolled
Thoracic

Ascites, Pleural Effusion, Pleural Effusion, Malignant

NCT00005906 2010-04-30

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
4 enrolled 8 charts
Thoracic

Ascites, Chylous Ascites, Chylothorax, Lymphangiomyoma, Pleural Effusion, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡